- Home
- AEON vs NUWE Comparison
AEON vs NUWE Comparison
Compare AEON & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- NUWE
- Stock Information
- Founded
- AEON N/A
- NUWE 1999
- Country
- AEON United States
- NUWE United States
- Employees
- AEON N/A
- NUWE N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AEON Health Care
- NUWE Health Care
- Exchange
- AEON Nasdaq
- NUWE Nasdaq
- Market Cap
- AEON 4.2M
- NUWE 3.9M
- IPO Year
- AEON N/A
- NUWE N/A
- Fundamental
- Price
- AEON $0.46
- NUWE $0.93
- Analyst Decision
- AEON Strong Buy
- NUWE Strong Buy
- Analyst Count
- AEON 1
- NUWE 1
- Target Price
- AEON $360.00
- NUWE $17.00
- AVG Volume (30 Days)
- AEON 465.0K
- NUWE 61.5K
- Earning Date
- AEON 05-13-2025
- NUWE 05-06-2025
- Dividend Yield
- AEON N/A
- NUWE N/A
- EPS Growth
- AEON N/A
- NUWE N/A
- EPS
- AEON 72.93
- NUWE N/A
- Revenue
- AEON N/A
- NUWE $8,740,000.00
- Revenue This Year
- AEON N/A
- NUWE $22.96
- Revenue Next Year
- AEON N/A
- NUWE $29.97
- P/E Ratio
- AEON $0.01
- NUWE N/A
- Revenue Growth
- AEON N/A
- NUWE N/A
- 52 Week Low
- AEON $0.38
- NUWE $0.75
- 52 Week High
- AEON $402.48
- NUWE $14.00
- Technical
- Relative Strength Index (RSI)
- AEON 26.87
- NUWE 47.12
- Support Level
- AEON $0.38
- NUWE $0.86
- Resistance Level
- AEON $0.43
- NUWE $0.95
- Average True Range (ATR)
- AEON 0.04
- NUWE 0.08
- MACD
- AEON 0.20
- NUWE 0.01
- Stochastic Oscillator
- AEON 56.29
- NUWE 76.71
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.